Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial

Fasching, Peter A.; Schem, Christian; Spilman, Patricia; Rabizadeh, Shahrooz; Soon-Shiong, Patrick; Warm, Mathias; Schneeweiss, Andreas; Schmatloch, Sabine; Nekljudova, Valentina; Untch, Michael; Budczies, Jan; Szeto, Christopher; Loibl, Sibylle; Denkert, Carsten; Karn, Thomas; Marmé, Frederik; Jackisch, Christian; Mueller, Volkmar; Sinn, Hans Peter; Stickeler, Elmar; van Mackelenbergh, Marion; Heinmöller, Ernst; Weber, Karsten; Benz, Stephen

doi:pmid:37014668

Information
References (0)
Discussion (0)
Files

Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial - RWTH-CONV-252403

Similar records

h1

h2

h3

h4

h5

h6

RWTH

Kontakt

RWTH Publications

Allgemeines